Physician profile
Scott Eric Chamberlain
NPI 1083867071
$3,756.28
in general payments reported to CMS, 2019-2025
12 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,255 · 2021: $247 · 2022: $66.49 · 2023: $165 · 2024: $688 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697 · Travel and Lodging: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.41 |
| Travel and Lodging | $490.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,684.22 | 2019 | |
| Medtronic, INC. | $624.26 | 2023-2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $484.32 | 2019-2025 | Intracept |
| Medtronic USA, INC. | $452.54 | 2019 | |
| Spr Therapeutics, INC | $148.81 | 2023-2024 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Redhill Biopharma INC. | $70.50 | 2021 | |
| Collegium Pharmaceutical, INC. | $54.41 | 2022 | |
| Grt US Holding, INC. | $45.00 | 2021 | |
| Abbott Laboratories | $23.49 | 2025 | Octrode |
| Vertos Medical, INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Chamberlain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.